Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neuropathic pain is usually managed pharmacologically, rather than with botulinum toxin type A (BTX-A). However, medications commonly fail to relieve pain effectively or have intolerable side effects. We present the case of a 62-year-old man diagnosed with an intracranial chondrosarcoma, which was removed surgically and treated with radiation therapy. He suffered from neuropathic pain despite combined pharmacological therapy with gabapentin, amitriptyline, tramadol, diazepam, and duloxetine because of adverse effects. BTX-A (100 units) was injected subcutaneously in the most painful area in the posterior left thigh. Immediately after the injection, his pain decreased significantly from 6/10 to 2/10 on a visual analogue scale. Pain relief lasted for 12 weeks. This case report describes intractable neuropathic pain caused by a brain tumor that was treated with subcutaneous BTX-A, which is a useful addition for the management of neuropathic pain related to a brain tumor.
Abstract
Neuropathic pain is usually managed pharmacologically, rather than with botulinum toxin type A (BTX-A). However, medications commonly fail to relieve pain effectively or have intolerable side effects. We present the case of a 62-year-old man diagnosed with an intracranial chondrosarcoma, which was removed surgically and treated with radiation therapy. He suffered from neuropathic pain despite combined pharmacological therapy with gabapentin, amitriptyline, tramadol, diazepam, and duloxetine because of adverse effects. BTX-A (100 units) was injected subcutaneously in the most painful area in the posterior left thigh. Immediately after the injection, his pain decreased significantly from 6/10 to 2/10 on a visual analogue scale. Pain relief lasted for 12 weeks. This case report describes intractable neuropathic pain caused by a brain tumor that was treated with subcutaneous BTX-A, which is a useful addition for the management of neuropathic pain related to a brain tumor.
참고문헌 (10)
- Watson JC, "Central neuropathic pain syndromes", Mayo Clin Proc, 91, pp.372~385 (2016)
- Liu HT, "Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia", Pain Med, 7, pp.89~91 (2006)
- Oh HM, "Botulinum toxin for neuropathic pain: a review of the literature", Toxins (Basel), 7, pp.3127~3154 (2015)
- Han ZA, "Botulinum toxin type A for neuropathic pain in patients with spinal cord injury", Ann Neurol, 79, pp.569~578 (2016)
- Cui M, "Subcutaneous administration of botulinum toxin A reduces formalin-induced pain", Pain, 107, pp.125~133 (2004)
- Aoki KR, "Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A", Neurotoxicology, 26, pp.785~793 (2005)
- Gazerani P, "Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin", Pain, 141, pp.60~69 (2009)
- Favre-Guilmard C, "Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models", Eur J Pharmacol, 617, pp.48~53 (2009)
- Tugnoli V, "Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin", Pain, 130, pp.76~83 (2007)
- Marinelli S, "The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes", PLoS One, 7, pp.e47977~ (2012)